Diabetes Discoveries & Practice Blog

Metformin and Chronic Kidney Disease (CKD)

Dr. C. Blake Cameron of Duke University School of Medicine, discusses his team’s research on clinical outcomes of metformin use in people with chronic kidney disease and explains what health care professionals need to know about changes to the FDA’s warning on metformin.

About the Author

C. Blake Cameron

MD, MBI

Dr. Cameron is a nephrologist and an assistant professor of medicine at Duke University School of Medicine. His practice focuses on caring for patients with CKD, kidney failure, and high blood pressure. He leads a chronic kidney disease “early warning” program for Duke’s accountable care organization designed to connect kidney patients to the right care at the right time.